Rapid Readouts: Efficacy of Novel Targeted Therapies Post-MURANO Study

Video

Related Videos
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Jean L. Koff, MD, MS
Lori A. Leslie, MD
Changchun Deng, MD, PhD
David L. Porter, MD, director, Cell Therapy and Transplant, Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Penn Medicine
Changchun Deng, MD, PhD
Guenther Koehne, MD, PhD
Ibrahim Aldoss, MD
Changchun Deng, MD, PhD, associate professor, hematology/oncology, University Hospitals Seidman Cancer Center; member, Immune Oncology Program, Case Comprehensive Cancer Center
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University
Related Content
Sattva S. Neelapu, MD

CAR T-Cell Agents Offer Efficacy in Lymphoma, But Additional Approaches Are Needed to Overcome Resistance

May 17th 2024
Article
OncLive On Air

Revisit the OncLive On Air Episodes From February 2024

March 18th 2024
Podcast
Jean L. Koff, MD, MS

Pirtobrutinib Transforms SOC in Later-Line CLL/SLL

May 14th 2024
Article
Matthew Lunning, DO, FACP

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

December 21st 2023
Podcast
Mohamad Mohty, MD, PhD, professor, hematology, head, Hematology and Cellular Therapy Department, Saint-Antoine Hospital and Sorbonne University; member, lead, translational research team, Saint-Antoine Research Center; chairman, Acute Leukemia Working Party, EBMT

Ongoing Research Aims to Expand Treatment Options, Address Unmet Needs in GVHD

May 12th 2024
Article
Bita Fakhri, MD, MPH

Second-Line Venetoclax Associated With Real-World Cost Savings vs BTK Inhibitors in CLL/SLL

May 7th 2024
Article